2/25/2021 8:02:26 AM
Allergan Submits NDA For AGN-190584 For The Treatment Of Presbyopia
2/24/2021 7:36:50 PM
AbbVie : FDA Approves HUMIRA To Treat Pediatric Patients Living With Moderately To Severely Active Ulcerative Colitis
2/22/2021 8:48:12 AM
AbbVie: Upadacitinib Met Primary Endpoint Of Clinical Remission,all Ranked Secondary Endpoint In Phase 3 Induction Study
2/19/2021 9:16:48 AM
AbbVie, Evolus And Medytox Announce Settlement Agreements To Fully Resolve All Outstanding Litigation
2/18/2021 11:05:48 AM
AbbVie (ABBV) Declares Quarterly Dividend of $ 1.30, Record Date 4/15/2021
2/18/2021 11:02:00 AM
AbbVie Declares Quarterly Dividend Of $1.30/share, Payable May 14/ Record April 15
2/10/2021 8:17:29 AM
AbbVie, Caribou Biosciences Enter Into Collaboration And License Agreement For CAR-T Cell Products
2/10/2021 8:02:00 AM
AbbVie : BOTOX Gets FDA Approval For Pediatric Detrusor Overactivity Associated With Neurologic Condition
2/3/2021 7:40:01 AM
AbbVie Q4 EPS $0.01 Vs $1.88 Last Year
1/26/2021 8:46:23 AM
Allergan Aesthetics Announces Launch Of CoolSculpting Elite
1/25/2021 12:05:06 PM
European Commission Approves AbbVie's Upadacitinib For The Treatment Of Psoriatic Arthritis And Ankylosing Spondylitis